Agilent Technologies, Inc. $A Position Trimmed by UNIVEST FINANCIAL Corp

UNIVEST FINANCIAL Corp lessened its position in shares of Agilent Technologies, Inc. (NYSE:A) by 74.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,818 shares of the medical research company’s stock after selling 5,327 shares during the period. UNIVEST FINANCIAL Corp’s holdings in Agilent Technologies were worth $313,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its holdings in shares of Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after purchasing an additional 2,440,360 shares during the period. Legal & General Group Plc purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth about $260,101,000. Bank of America Corp DE purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth about $213,269,000. Man Group plc acquired a new stake in Agilent Technologies during the 2nd quarter worth approximately $179,257,000. Finally, Primecap Management Co. CA acquired a new stake in Agilent Technologies during the 2nd quarter worth approximately $176,318,000.

Insider Activity at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Analyst Upgrades and Downgrades

Several research firms recently commented on A. Deutsche Bank started coverage on shares of Agilent Technologies in a report on Monday, October 26th. They issued a “buy” rating and a $190.00 price target on the stock. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $190.00 to $195.00 in a research report on Wednesday, October 14th. Citigroup increased their price objective on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Morgan Stanley raised their target price on shares of Agilent Technologies from $175.00 to $190.00 and gave the company an “overweight” rating in a research note on Tuesday, October 13th. Finally, Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $181.45.

Agilent Technologies Price Performance

A stock opened at $173.19 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $182.99. The firm has a market cap of $48.83 billion, a P/E ratio of 34.09, a price-to-earnings-growth ratio of 2.59 and a beta of 1.24. The stock has a 50-day simple moving average of $167.93 and a 200-day simple moving average of $138.00.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The company’s revenue was up 8.1% on a year-over-year basis. During the same period last year, the business posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th were paid a dividend of $0.2550 per share. The ex-dividend date was Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.

Agilent Technologies Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.